Search For

The polygenic risk score in the breast cancer treatment

Risk factors influencing chronic inflammation in neoplastic transition to prostate cancer

Fabry nephropathy: focus on podocyte damage and therapeutic target

In memory of Nathan A. Berger, MD

The diagnostic odyssey, clinical burden, and natural history of Barth syndrome: an analysis of patient registry data

Commentary on “transcription regulation by long non-coding RNAs: mechanisms and disease relevance”

Unraveling the genetic tapestry of neurodevelopmental disorders: a new horizon

The reactive stroma response regulates the immune landscape in prostate cancer

Duchenne muscular dystrophy: diagnosis and perspective of treatment

The potential therapeutic applications of long non-coding RNAs

Reduced protein kinase C delta in a high molecular weight complex in mitochondria and elevated creatine uptake into Barth syndrome B lymphoblasts

Challenges in determining the malignant potential of atypical neurofibromas (aNF) using histopathologic features and the potential need for CDKN2A/2B testing: a case report